| Primary |
| Product Used For Unknown Indication |
16.7% |
| Syncope Vasovagal |
16.7% |
| Blood Pressure |
8.3% |
| Drug Use For Unknown Indication |
8.3% |
| Gout |
8.3% |
| Hypotension |
8.3% |
| Local Anaesthesia |
8.3% |
| Orthostatic Hypotension |
8.3% |
| Orthostatic Intolerance |
8.3% |
| Vasoconstriction |
8.3% |
|
| Atrial Fibrillation |
10.0% |
| Loss Of Consciousness |
10.0% |
| Muscular Weakness |
10.0% |
| Pollakiuria |
10.0% |
| Rhinorrhoea |
10.0% |
| Skin Ulcer |
10.0% |
| Syncope |
10.0% |
| Tachycardia |
10.0% |
| Transient Ischaemic Attack |
10.0% |
| Vaginal Disorder |
10.0% |
|
| Secondary |
| Orthostatic Hypotension |
100.0% |
|
| Stevens-johnson Syndrome |
100.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.7% |
| Drug Use For Unknown Indication |
28.5% |
| Nuclear Magnetic Resonance Imaging |
2.8% |
| Angiogram |
1.6% |
| Multiple Myeloma |
1.6% |
| Acute Myeloid Leukaemia |
1.1% |
| Hypercalcaemia Of Malignancy |
1.1% |
| Atrial Fibrillation |
1.0% |
| Cardiac Operation |
1.0% |
| Nuclear Magnetic Resonance Imaging Abdominal |
0.8% |
| Nuclear Magnetic Resonance Imaging Brain |
0.7% |
| Muscle Spasms |
0.6% |
| Osteoporosis |
0.6% |
| Hypercalcaemia |
0.6% |
| Pain |
0.6% |
| Peritoneal Dialysis |
0.6% |
| Thrombosis Prophylaxis |
0.5% |
| Toothache |
0.5% |
| Depression |
0.5% |
| Orthostatic Hypotension |
0.5% |
|
| Weight Decreased |
15.6% |
| Syncope |
9.4% |
| Wound Dehiscence |
8.3% |
| Vomiting |
7.3% |
| X-ray Abnormal |
7.3% |
| Nephrogenic Systemic Fibrosis |
6.3% |
| Orthostatic Hypotension |
5.2% |
| Thrombosis |
5.2% |
| Ventricular Arrhythmia |
5.2% |
| Swelling |
4.2% |
| Urticaria |
4.2% |
| Pneumonia |
3.1% |
| Renal Failure Acute |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Arthralgia |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Death |
2.1% |
| Drug Ineffective |
2.1% |
| Ejection Fraction Decreased |
2.1% |
| Insomnia |
2.1% |
|
